Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cellectis S.A. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q3 2023
- Shares held
- 9.82M
- −1.66M (−14.5%) vs. Q3 2023
- Total value
- $30.2M
- +$12.1M (+66.7%) vs. Q3 2023
- New holders
- 9
- 6 more added
- Sold out
- 6
- 7 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $13.8M | 1.79% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $5.69M | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 1,438,255 | $4.43M | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 816,643 | $2.52M | 0.00% | −347,366−29.8% | Reduced |
| Principal Financial Group Inc | 399,627 | $1.23M | 0.00% | −256,973−39.1% | Reduced |
| Macquarie Group Ltd | 226,875 | $699.0K | 0.00% | 00.0% | Unchanged |
| KBC Group NV | 163,447 | $503.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 133,143 | $410.1K | 0.01% | +11,723+9.7% | Added |
| Morgan Stanley | 76,225 | $234.8K | 0.00% | +8,633+12.8% | Added |
| LPL Financial LLC | 72,187 | $222.3K | 0.00% | +8,530+13.4% | Added |
| Two Sigma Investments, LP | 52,247 | $160.9K | 0.00% | +52,247 | New |
| Susquehanna International Group, LLP | 19,524 | $60.1K | 0.00% | +19,524 | New |
| Citadel Advisors LLC | 17,784 | $54.8K | 0.00% | −16,516−48.2% | Reduced |
| BNP Paribas Arbitrage, SA | 15,800 | $48.7K | 0.00% | +4,856+44.4% | Added |
| Wells Fargo & Company | 14,294 | $44.0K | 0.00% | −1,250−8.0% | Reduced |
| Geode Capital Management, LLC | 10,776 | $33.2K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,580 | $14.1K | 0.00% | −4,390−48.9% | Reduced |
| Qube Research & Technologies Ltd | 4,477 | $13.8K | 0.00% | +4,437+11,092.5% | Added |
| Rhumbline Advisers | 3,855 | $11.9K | 0.00% | +885+29.8% | Added |
| National Bank of Canada | 3,600 | $11.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,755 | $8.48K | 0.00% | 00.0% | Unchanged |
| Tennessee Valley Asset Management Partners | 2,430 | $7.48K | 0.00% | +2,430 | New |
| Baystate Wealth Management LLC | 500 | $1.54K | 0.00% | +500 | New |
| Allworth Financial LP | 500 | $1.54K | 0.00% | +500 | New |
| POM Investment Strategies, LLC | 495 | $1.52K | 0.00% | +495 | New |
| Group One Trading, L.P. | 330 | $1.02K | 0.00% | +330 | New |
| UBS Group AG | 100 | $308 | 0.00% | −3,935−97.5% | Reduced |
| JPMorgan Chase & Co | 83 | $256 | 0.00% | −4,940−98.3% | Reduced |
| FMR LLC | 40 | $123 | 0.00% | +40 | New |
| Toronto Dominion Bank | 31 | $95 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $40 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 10 | $32 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 200 | $0 | 0.00% | +200 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,095,966−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −47,154−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −56−100.0% | Sold out |